Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 3937842, 10 pages
https://doi.org/10.1155/2017/3937842
Research Article

Concurrent Aerobic and Resistance Training Has Anti-Inflammatory Effects and Increases Both Plasma and Leukocyte Levels of IGF-1 in Late Middle-Aged Type 2 Diabetic Patients

1Department of Biomolecular Sciences, Division of Exercise and Health Sciences, University of Urbino Carlo Bo, Urbino, Italy
2Department of Diabetology and Endocrinology, Asur Marche Area Vasta 1, S. Maria della Misericordia Hospital, Urbino, Italy

Correspondence should be addressed to Giosuè Annibalini

Received 5 April 2017; Accepted 23 May 2017; Published 21 June 2017

Academic Editor: Mauricio Krause

Copyright © 2017 Giosuè Annibalini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Y. Donath and S. E. Shoelson, “Type 2 diabetes as an inflammatory disease,” Nature Reviews. Immunology, vol. 11, pp. 98–107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. R. Kalyani, M. Corriere, and L. Ferrucci, “Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases,” The Lancet Diabetes and Endocrinology, vol. 2, pp. 819–829, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” The Journal of Clinical Investigation, vol. 116, pp. 1793–1801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Qatanani and M. A. Lazar, “Mechanisms of obesity-associated insulin resistance: many choices on the menu,” Genes & Development, vol. 21, pp. 1443–1455, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Andrade-Oliveira, N. O. Camara, and P. M. Moraes-Vieira, “Adipokines as drug targets in diabetes and underlying disturbances,” Journal of Diabetes Research, vol. 2015, Article ID 681612, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. U. J. Jung and M. S. Choi, “Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease,” International Journal of Molecular Sciences, vol. 15, pp. 6184–6223, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Efstratiadis, G. Tsiaousis, V. G. Athyros et al., “Total serum insulin-like growth factor-1 and C-reactive protein in metabolic syndrome with or without diabetes,” Angiology, vol. 57, pp. 303–311, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. R. Bernal-Lopez, V. Llorente-Cortes, F. Calleja et al., “Effect of different degrees of impaired glucose metabolism on the expression of inflammatory markers in monocytes of patients with atherosclerosis,” Acta Diabetologica, vol. 50, pp. 553–562, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Giulietti, E. van Etten, L. Overbergh, K. Stoffels, R. Bouillon, and C. Mathieu, “Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D3 works as anti-inflammatory,” Diabetes Research and Clinical Practice, vol. 77, pp. 47–57, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Balducci, S. Zanuso, A. Nicolucci et al., “Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss,” Nutrition, Metabolism, and Cardiovascular Diseases, vol. 20, pp. 608–617, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. E. T. de Lemos, J. Oliveira, J. P. Pinheiro, and F. Reis, “Regular physical exercise as a strategy to improve antioxidant and anti-inflammatory status: benefits in type 2 diabetes mellitus,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 741545, 15 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Krause, J. Rodrigues-Krause, C. O’Hagan et al., “The effects of aerobic exercise training at two different intensities in obesity and type 2 diabetes: implications for oxidative stress, low-grade inflammation and nitric oxide production,” European Journal of Applied Physiology, vol. 114, pp. 251–260, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. L. U. Monzillo, O. Hamdy, E. S. Horton et al., “Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance,” Obesity Research, vol. 11, pp. 1048–1054, 2003. View at Publisher · View at Google Scholar
  14. G. A. Kelley and K. S. Kelley, “Effects of aerobic exercise on C-reactive protein, body composition, and maximum oxygen consumption in adults: a meta-analysis of randomized controlled trials,” Metabolism, vol. 55, pp. 1500–1507, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. L. C. Melo, J. Dativo-Medeiros, C. E. Menezes-Silva, F. T. Barbosa, C. F. Sousa-Rodrigues, and L. A. Rabelo, “Physical exercise on inflammatory markers in type 2 diabetes patients: a systematic review of randomized controlled trials,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 8523728, 10 pages, 2017. View at Publisher · View at Google Scholar
  16. A. Oberbach, S. Lehmann, K. Kirsch et al., “Long-term exercise training decreases interleukin-6 (IL-6) serum levels in subjects with impaired glucose tolerance: effect of the -174G/C variant in IL-6 gene,” European Journal of Endocrinology, vol. 159, pp. 129–136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. L. Jorge, V. N. de Oliveira, N. M. Resende et al., “The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus,” Metabolism, vol. 60, pp. 1244–1252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. N. J. Snowling and W. G. Hopkins, “Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis,” Diabetes Care, vol. 29, pp. 2518–2527, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. E. T. Poehlman, R. V. Dvorak, W. F. DeNino, M. Brochu, and P. A. Ades, “Effects of resistance training and endurance training on insulin sensitivity in nonobese, young women: a controlled randomized trial,” The Journal of Clinical Endocrinology and Metabolism, vol. 85, pp. 2463–2468, 2000. View at Publisher · View at Google Scholar
  20. J. Lee, D. Kim, and C. Kim, “Resistance training for glycemic control, muscular strength, and lean body mass in old type 2 diabetic patients: a meta-analysis,” Diabetes Therapy, vol. 8, pp. 459–473, 2017. View at Publisher · View at Google Scholar
  21. S. R. Colberg, R. J. Sigal, J. E. Yardley et al., “Physical activity/exercise and diabetes: a position statement of the American Diabetes Association,” Diabetes Care, vol. 39, pp. 2065–2079, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. S. R. Colberg, A. L. Albright, B. J. Blissmer et al., “Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement,” Diabetes Care, vol. 33, pp. e147–e167, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. C. E. Garber, B. Blissmer, M. R. Deschenes et al., “American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise,” Medicine and Science in Sports and Exercise, vol. 43, no. 7, pp. 1334–1359, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. American Diabetes Association, “Standards of medical care in diabetes—2013,” Diabetes Care, vol. 36, Supplement 1, pp. S11–S66, 2013. View at Google Scholar
  25. J. F. Sallis, W. L. Haskell, P. D. Wood et al., “Physical activity assessment methodology in the Five-City Project,” American Journal of Epidemiology, vol. 121, pp. 91–106, 1985. View at Publisher · View at Google Scholar
  26. S. H. Knudsen and B. K. Pedersen, “Targeting inflammation through a physical active lifestyle and pharmaceuticals for the treatment of type 2 diabetes,” Current Diabetes Reports, vol. 15, p. 82, 2015. View at Google Scholar
  27. W. R. Thompson, N. F. Gordon, and L. S. Pescatello, ACSM’s Guidelines for Exercise Testing and Prescription, Lippincott Williams & Wilkins, Philadelphia, 8th ed edition, 2010, xxi.
  28. R. L. Gellish, B. R. Goslin, R. E. Olson, A. McDonald, G. D. Russi, and V. K. Moudgil, “Longitudinal modeling of the relationship between age and maximal heart rate,” Medicine and Science in Sports and Exercise, vol. 39, pp. 822–829, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Brzycki, “Strength testing—predicting a one-rep max from reps-to-fatigue,” Journal of Physical Education, Recreation & Dance, vol. 64, pp. 88–90, 1993. View at Publisher · View at Google Scholar
  30. M. W. Pfaffl, “A new mathematical model for relative quantification in real-time RT-PCR,” Nucleic Acids Research, vol. 29, p. e45, 2001. View at Google Scholar
  31. X. Liu, Q. Feng, Y. Chen et al., “Proteomics-based identification of differentially-expressed proteins including galectin-1 in the blood plasma of type 2 diabetic patients,” Journal of Proteome Research, vol. 8, pp. 1255–1262, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,” Analytical Biochemistry, vol. 72, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Sestili, E. Barbieri, C. Martinelli et al., “Creatine supplementation prevents the inhibition of myogenic differentiation in oxidatively injured C2C12 murine myoblasts,” Molecular Nutrition & Food Research, vol. 53, pp. 1187–1204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Sinha, J. Poland, M. Schnolzer, and T. Rabilloud, “A new silver staining apparatus and procedure for matrix-assisted laser desorption/ionization-time of flight analysis of proteins after two-dimensional electrophoresis,” Proteomics, vol. 1, pp. 835–840, 2001. View at Publisher · View at Google Scholar
  35. A. Shevchenko, M. Wilm, O. Vorm, and M. Mann, “Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels,” Analytical Chemistry, vol. 68, pp. 850–858, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Guescini, D. Guidolin, L. Vallorani et al., “C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction,” Experimental Cell Research, vol. 316, pp. 1977–1984, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. E. Barbieri, M. Battistelli, L. Casadei et al., “Morphofunctional and biochemical approaches for studying mitochondrial changes during myoblasts differentiation,” Journal of Aging Research, vol. 2011, Article ID 845379, 16 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Herder, M. Peltonen, W. Koenig et al., “Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study,” Diabetologia, vol. 52, pp. 433–442, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. A. Brunton, “The changing shape of type 2 diabetes,” Medscape Journal of Medicine, vol. 10, p. 143, 2008, quiz 143. View at Google Scholar
  40. L. Zemany, S. Bhanot, O. D. Peroni et al., “Transthyretin antisense oligonucleotides lower circulating RBP4 levels and improve insulin sensitivity in obese mice,” Diabetes, vol. 64, pp. 1603–1614, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. Q. Yang, T. E. Graham, N. Mody et al., “Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes,” Nature, vol. 436, pp. 356–362, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Iikuni, Q. L. Lam, L. Lu, G. Matarese, and A. La Cava, “Leptin and inflammation,” Current Immunology Reviews, vol. 4, pp. 70–79, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. W. H. Sheu, T. M. Chang, W. J. Lee et al., “Effect of weight loss on proinflammatory state of mononuclear cells in obese women,” Obesity (Silver Spring), vol. 16, pp. 1033–1038, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. V. Touskova, P. Trachta, P. Kavalkova et al., “Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: the influence of very-low-calorie diet,” Molecular and Cellular Endocrinology, vol. 361, pp. 172–178, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Buch, E. Carmeli, L. K. Boker et al., “Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age—an overview,” Experimental Gerontology, vol. 76, pp. 25–32, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. I. Janssen, “The epidemiology of sarcopenia,” Clinics in Geriatric Medicine, vol. 27, pp. 355–363, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. T. N. Kim, M. S. Park, S. J. Yang et al., “Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS),” Diabetes Care, vol. 33, pp. 1497–1499, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Schiaffino and C. Mammucari, “Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models,” Skeletal Muscle, vol. 1, p. 4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. D. R. Clemmons, “Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes,” Endocrinology and Metabolism Clinics of North America, vol. 41, pp. 425–443, 2012, vii-viii. View at Publisher · View at Google Scholar · View at Scopus
  50. E. Barbieri, D. Agostini, E. Polidori et al., “The pleiotropic effect of physical exercise on mitochondrial dynamics in aging skeletal muscle,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 917085, 15 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. S. E. Borst, D. V. De Hoyos, L. I. Garzarella et al., “Effects of resistance training on insulin-like growth factor-I and IGF binding proteins,” Medicine and Science in Sports and Exercise, vol. 33, pp. 648–653, 2001. View at Google Scholar
  52. H. Lu, D. Huang, N. Saederup, I. F. Charo, R. M. Ransohoff, and L. Zhou, “Macrophages recruited via CCR2 produce insulin-like growth factor-1 to repair acute skeletal muscle injury,” The FASEB Journal, vol. 25, pp. 358–369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Tonkin, L. Temmerman, R. D. Sampson et al., “Monocyte/macrophage-derived IGF-1 orchestrates murine skeletal muscle regeneration and modulates autocrine polarization,” Molecular Therapy, vol. 23, pp. 1189–1200, 2015. View at Publisher · View at Google Scholar · View at Scopus
  54. D. Davalos and K. Akassoglou, “Fibrinogen as a key regulator of inflammation in disease,” Seminars in Immunopathology, vol. 34, pp. 43–62, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Groop, A. Makipernaa, S. Stenman, R. A. DeFronzo, and A. M. Teppo, “Urinary excretion of kappa light chains in patients with diabetes mellitus,” Kidney International, vol. 37, pp. 1120–1125, 1990. View at Publisher · View at Google Scholar
  56. C. A. Hutchison, P. Cockwell, S. Harding, G. P. Mead, A. R. Bradwell, and A. H. Barnett, “Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes: an early marker of diabetic kidney disease?” Expert Opinion on Therapeutic Targets, vol. 12, pp. 667–676, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. H. S. Bhonsle, A. M. Korwar, A. D. Chougale et al., “Proteomic study reveals downregulation of apolipoprotein A1 in plasma of poorly controlled diabetes: a pilot study,” Molecular Medicine Reports, vol. 7, pp. 495–498, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. M. B. Sasongko, T. Y. Wong, T. T. Nguyen et al., “Serum apolipoproteins are associated with systemic and retinal microvascular function in people with diabetes,” Diabetes, vol. 61, pp. 1785–1792, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. N. Cheung, P. Mitchell, and T. Y. Wong, “Diabetic retinopathy,” Lancet, vol. 376, pp. 124–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Umpierre, P. A. Ribeiro, C. K. Kramer et al., “Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis,” Jama, vol. 305, pp. 1790–1799, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. N. D. Eves and R. C. Plotnikoff, “Resistance training and type 2 diabetes: considerations for implementation at the population level,” Diabetes Care, vol. 29, pp. 1933–1941, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Byrne, B. Caulfield, and G. De Vito, “Effects of self-directed exercise programmes on individuals with type 2 diabetes mellitus: a systematic review evaluating their effect on HbA1c and other metabolic outcomes, physical characteristics, cardiorespiratory fitness and functional outcomes,” Sports Medicine, vol. 47, pp. 717–733, 2017. View at Publisher · View at Google Scholar · View at Scopus